Acesso TL

Acesso TL is a dehydrated, triple-layer, amnion-derived human allograft membrane used as a skin substitute for advanced wound care, providing a protective covering and barrier over acute and chronic wounds while supporting tissue repair through its extracellular matrix scaffold and retained bioactive components.[1][3][4][5][9][12][13] Developed and marketed by Acesso Biologics, it is processed under Good Tissue Practices to optimize strength, thickness, and tissue adherence compared with single- or dual-layer amniotic membranes, is shelf-stable at room temperature for several years, and is applied by clinicians directly to the wound bed using standard fixation methods.[2][3][4][9][12][13] Acesso TL is billed under HCPCS Q4300 in the United States as a skin substitute/biologic for wound management.[3][7][10][14]

Brand names

Acesso TL